Wendy's Rejects Trian's $1.4 Billion Bid and Adopts a Poison Pill

Wendy's board had two ways to fix the burger chain: sell it to a group that includes one of its biggest franchisees, or bet on a turnaround plan it unveiled the same morning. It picked the plan.

A committee of independent directors unanimously rejected the $7.35-a-share cash offer from Trian Fund Management, Flynn Group, BlueFive Capital and Sixth Street Partners, the company said Nov. 5. The committee said the proposal "substantially undervalues" Wendy's and does not reflect the value it expects from Dave's Way, the multi-year strategy chief executive Bob Wright laid out in the third-quarter earnings release.

"Our confidence rests firmly in Bob Wright's proven track record of seasoned industry leadership, including restaurant business turnarounds," said Art Winkleblack, the board's chairman and a member of the committee.

The board also adopted a one-year shareholder rights plan on Nov. 4, according to a filing with the SEC. If a person or group reaches 15% of the stock without board approval, or a holder already above 15% buys more, every other shareholder can buy additional shares at a steep discount. The plan expires Nov. 3, 2027. Wendy's said it acted in part because the investor group turned down a standstill agreement, which would have paused further share purchases.

The threshold is not academic. Trian and related parties own 16.3% of Wendy's, Reuters reported. The group already sits above the line, so buying more would trigger the plan.

The rejection closes a loop that opened Oct. 28, when Trian brought Flynn Group into its bid. The same earnings report explains why an offer was on the table at all: U.S. same-restaurant sales fell 5.7% in the third quarter, and Wendy's said it signed a letter of intent to buy up to 163 restaurants from bankrupt franchisee Meritage.

For other franchisees, the awkward part is that one of their own is on the losing side. Flynn Group is among the system's largest operators, and its partners argued a turnaround works better away from quarterly scrutiny. The board is now asking every operator to execute Dave's Way under exactly that scrutiny. Winkleblack said management had already presented the plan to franchisees at the 2026 Wendy's convention.

Wendy's is the third public franchisor in recent weeks to answer buyout interest with a poison pill. Dine Brands did it for Applebee's and IHOP in late October, and Xponential Fitness adopted one earlier that month.

Trian declined to comment, CNBC reported. Its options are the usual ones: raise the price, take the fight to a proxy vote, or wait to see whether sales turn. The pill buys Wendy's a year. The next few quarters of comps will decide whether it needs all of it.